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Streptococcus equi is the causative agent of strangles, a prevalent and highly contagious disease of horses.
Despite the animal suffering and economic burden associated with strangles, little is known about the
molecular basis of S. equi virulence. Here we have investigated the contributions of a specific lipoprotein and
the general lipoprotein processing pathway to the abilities of S. equi to colonize equine epithelial tissues in vitro
and to cause disease in both a mouse model and the natural host in vivo. Colonization of air interface organ
cultures after they were inoculated with a mutant strain deficient in the maturase lipoprotein (prtM138-213,
with a deletion of nucleotides 138 to 213) was significantly less than that for cultures infected with wild-type
S. equi strain 4047 or a mutant strain that was unable to lipidate preprolipoproteins (lgt190-685). Moreover,
mucus production was significantly greater in both wild-type-infected and lgt190-685-infected organ cultures.
Both mutants were significantly attenuated compared with the wild-type strain in a mouse model of strangles,
although 2 of 30 mice infected with the lgt190-685 mutant did still exhibit signs of disease. In contrast, only the
prtM138-213 mutant was significantly attenuated in a pony infection study, with 0 of 5 infected ponies
exhibiting pathological signs of strangles compared with 4 of 4 infected with the wild-type and 3 of 5 infected
with the lgt190-685 mutant. We believe that this is the first study to evaluate the contribution of lipoproteins
to the virulence of a gram-positive pathogen in its natural host. These data suggest that the PrtM lipoprotein
is a potential vaccine candidate, and further investigation of its activity and its substrate(s) are warranted.
The group C streptococcus, Streptococcus equi, is the etiological
agent of strangles, one of the most prevalent and important
diseases of the horse (52). Nearly 30% of all reported equine
infections worldwide may be attributable to this organism (8).
Strangles is so called because of the pharyngeal constriction
which occurs as a consequence of lymph node swelling (often
accompanied by abscess formation) in the upper respiratory
tract of the horse following the spread of infection from the
nasopharynx. In approximately 5% of cases, systemic spread of
the organism leads to abscess formation in other organs, re-
sulting in the usually fatal condition known as “bastard stran-
gles” (44). There is comparatively little information regarding
the molecular basis of virulence in S. equi (22). As for other
pathogenic streptococci (4, 15, 32, 38), much work has focused
on the identification of secreted and surface-located compo-
nents that may interact with the host (2, 17, 22, 27, 35). A
major development in the study of this important veterinary
pathogen has been the availability of data from the S. equi
genome project (http://www.sanger.ac.uk/Projects/S_equi/).
One major mechanism by which gram-positive bacteria can
retain exported proteins within their cell envelopes is lipid
modification, which anchors these lipoproteins to the outer
face of the plasma membrane (6, 48). Bioinformatic analyses of
gram-positive bacterial genomes, including those of Strepto-
coccus pneumoniae, Streptococcus pyogenes, and Streptococcus
agalactiae, have revealed that lipoproteins are a numerically
significant feature (ca. 2%) of their predicted proteomes (3, 46,
47, 50, 51). Moreover, the predicted functions of these putative
lipoproteins include roles in nutrient acquisition, adherence,
protein maturation, and cell signaling. Thus, lipoproteins are
predicted to play important roles in the interactions between
pathogenic bacteria and their hosts. Three S. equi lipoproteins
have been characterized to date: LppC, a lipoprotein acid
phosphatase enzyme (21); MBL, a putative metal-binding li-
poprotein homologous to pneumococcal PsaA that is predicted
to participate in ABC transporter-mediated uptake of manga-
nese (23); and HAP, initially identified as hyaluronate (cap-
sule)-associated protein (10) but which is likely to act as a
substrate-binding lipoprotein for ABC transporter-mediated
uptake of oligopeptides (22). Bioinformatic analysis of the
draft S. equi genome sequence has allowed us to identify at
least 32 other putative lipoproteins (I. C. Sutcliffe and D. J.
Harrington, unpublished observations), including a homologue
(PrtM) of the pneumococcal vaccine candidate PpmA (33).
Recently, the signal sequences of five of these putative lipopro-
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teins were recovered in a screen for signal peptides, using a
phage display technique (27).
Bacterial lipoproteins are synthesized with distinctive type II
signal peptides that direct them into the Sec pathway for
protein export (6, 18) and thence into a unique modification
pathway which requires a minimum of two specific enzymes.
First, prolipoprotein diacylglyceryl transferase (Lgt) trans-
fers a diacylglycerol moiety from membrane phospholipid sub-
strates onto a critical cysteine residue in the cleavage region
(“lipobox”) of the type II signal peptide (36, 42). The lipid-
modified prolipoprotein is then acted upon by a dedicated
lipoprotein signal peptidase (Lsp) which cleaves the signal
sequence preceding the thioether-modified cysteine, thereby
leaving the lipid anchor unit at the N terminus of the mature
lipoprotein (41, 54). These two steps are sufficient for lipopro-
tein anchoring and appear to be the extent of the pathway in
many gram-positive bacteria (46, 47).
This pathway for lipid modification of bacterial proteins is
an attractive target for antimicrobial drug development, as
both the Lgt and Lsp enzymes are unique to prokaryotes.
Likewise, as lipoproteins are likely to play important roles in
host colonization and bacterial virulence, individual lipopro-
teins have potential as targets for novel therapeutic or prophy-
lactic (vaccine) strategies (28). Consistent with this are the
findings that, although Lgt is not apparently an essential en-
zyme during in vitro growth of gram-positive bacteria (12, 29,
34, 39), an lgt mutant strain of S. pneumoniae was attenuated
for virulence in a mouse model of infection (34) and the nor-
mal functions of Bacillus subtilis lipoproteins in protein secre-
tion, sporulation, and germination processes are impaired in lgt
mutants (12, 25, 29, 39). Moreover, an Lgt mutant of Staphy-
lococcus aureus that grew normally in rich media exhibited
growth defects in minimal media, consistent with defects in
lipoprotein-mediated nutrient uptake systems, notably ABC
transporters (45). Similarly, although lsp is dispensable for the
growth of gram-positive bacteria in vitro (13, 37, 40, 53, 55),
studies using cell culture or animal models of infection show
that lsp is required for full virulence of Listeria monocytogenes
(37), Mycobacterium tuberculosis (40), and S. aureus (11, 30). In
contrast, inactivation of lsp in Streptococcus suis did not appear
to lead to an attenuation in virulence in a cocolonization model
of piglet infection (13).
We hypothesized that the lipid modification pathway is es-
sential for full virulence of S. equi. As the Lgt enzyme catalyzes
the first and committed step on this path, we initially studied
the contribution of this enzyme to the physiology and virulence
of S. equi. In parallel, we investigated the deletion of a single,
specific lipoprotein, namely the putative maturase lipoprotein
(PrtM). We believe that this is the first study to evaluate the
contribution of lipoproteins to the virulence of a gram-positive
bacterial pathogen in its natural host.
MATERIALS AND METHODS
Bacterial strains and culture conditions. S. equi strain 4047 was originally
isolated in 1990 from a submandibular abscess of a New Forest pony and has
been maintained in the culture collection of the Animal Health Trust, Newmar-
ket, United Kingdom. This strain is the subject of the S. equi genome sequencing
project. Escherichia coli TG1 repA, which allows the stable replication of the
plasmid pGhost9 at 37°C, was kindly supplied by Emmanuelle Maguin (Institut
Nationale de la Recherche Agronomique, Jouy en Josas, France). S. equi was
cultured at 37°C (unless otherwise stated). Liquid cultures were grown in Todd-
Hewitt broth (THB) plus 0.2% (wt/vol) yeast extract in an atmosphere containing
5% CO2. Semisolid cultures were grown on Todd-Hewitt agar (THA) or Co-
lumbia base agar containing 5% defibrinated horse blood in an atmosphere
containing 5% CO2. Mutant S. equi strains containing recombinant plasmids
were grown on THA containing erythromycin at 0.5 g ml1 (THAE) or in THB
containing erythromycin at 1.0 g ml. E. coli strains were cultured in Luria-
Bertani (LB) broth or agar at 37°C.
Plasmids and primers. The plasmids and primers used in this study are shown
in Table 1.
Construction of in-frame-deleted lgt and prtM alleles. In order to generate
Lgt-deficient and PrtM-deficient mutants of S. equi 4047 by allelic replacement,
copies of the S. equi lgt and prtM genes containing in-frame deletions were
constructed. The design for the Lgt mutant PCR primers (SELGTAR 1U, 2L,
3U, and 4L) (Table 1) was based upon sequences found within the lgt gene and
adjacent sequences. The 22 nucleotides at the 5 end of primer SELGTAR 3U
were designed to complement the SELGTAR 2L primer sequence. PCR using
Pfu polymerase (Promega), S. equi 4047 chromosomal DNA, and primers
SELGTAR 1U and SELGTAR 2L generated the expected 526-bp DNA frag-
ment. A second PCR with the SELGTAR 3U and SELGTAR 4L primers
generated the expected 496-bp DNA fragment. The PCR products from each
reaction were diluted, mixed, and allowed to anneal via their overlapping, com-
plementary ends. A third PCR was then carried out with these annealed DNA
TABLE 1. Oligonucleotide primers and plasmids used in this study
Primer or plasmid Sequence or description Reference
Primera
SELGTAR 1U 5-GGGCCCGTCATCTCCTTGAGATTCGTG-3
SELGTAR 2L 5-GATTCTTGCTCCAATAATTGCC-3
SELGTAR 3U 5-GGCAATTATTGGAGCAAGAATCGTTTCTCAATACATGTCGGTG-3
SELGTAR 4L 5-CCGCGGATAATTTAGAAGCGACCTTGC-3
5PRTM 5-GGGGAATTCAAGTGTCATTACGATGAAGG-3
PRTM-NDEL 5-GGGGATATCGTAATCAGCATCTGTCAGCTC-3
3PRTM 5-GGGGTCGACTTTCTGACTTAGATTTAGAAG-3
PRTM-CDEL 5-GGGGATATCGAGGGTGATATTTCAGAGGTG-3
Plasmid
pGhost9:ISS1 Replication-thermosensitive derivative of pWV01 containing cloned ISS1 sequence 29a
pAH08 pGhost9:ISS1b containing in-frame-deleted lgt gene of S. equi This study
pGprtM pGhost9:ISS1b ISS1 containing in-frame-deleted prtM gene of S. equi This study
pGEM-T T-A cloning vector Promega
a Underlined sequences represent engineered restriction sites for ApaI (GGGCCC), SacII (CCGCGG), EcoRI (GAATTC), EcoRV (GATATC), and SalI
(GTCGAC). The italicized sequence in SELGTAR 3U is the reverse and complementary sequence to the primer SELGTAR 2L sequence and provides the overlapping
sequence for the overlap-deletion PCR strategy.
b The ISS1 sequence is completely removed during cloning strategy.
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fragments as a template and with primers SELGTAR 1U and SELGTAR 4L,
again using the Pfu polymerase. The product of this reaction was a DNA frag-
ment of 1,022 bp containing the 5 189 base pairs and 3 96 base pairs (plus
upstream and downstream sequences) but lacking the central 495 bp of the lgt
gene. The fragment was digested with the restriction endonucleases ApaI and
SacII and cloned into the corresponding restriction sites of the pGHost9 vector
to give the recombinant plasmid pAH08. To generate a PrtM mutant, a copy of
the prtM gene that lacked bases 411 to 639, which include the sequence encoding
most of the parvulin-like domain of the protein, was constructed. Sequences
flanking the deletion were generated by PCR using Vent DNA polymerase (New
England Biolabs) with the primer pairs 5PRTM/PRTM-NDEL and 3PRTM/
PRTM-CDEL (Table 1). The corresponding 342-bp and 376-bp PCR products
were then digested with the restriction endonucleases EcoRI and EcoRV (5
product) and SalI and EcoRV (3 product), and the digested products were
ligated into the EcoRI- and SalI-digested pGHost9:ISS1 plasmid in a three-
way ligation to form the deletion construct pGprtM. Engineering of an EcoRV
site into primers as part of the cloning strategy results in the introduction of a
non-prtM DNA sequence encoding the amino acids aspartic acid and isoleucine
at the site of the deletion. Plasmids pAH08 and pGprtM were transformed into
E. coli TG1repA, and transformants were selected at 37°C on LB plates con-
taining erythromycin (150 g ml1).
Allelic-replacement mutagenesis. Transformation of the encapsulated S. equi
strain 4047 with plasmids pAH08 and pGprtM was achieved using a modifica-
tion of the method described by Simon and Ferretti (43). Briefly, an overnight
culture of S. equi 4047 grown in THB containing hyaluronidase (30 g ml1) was
diluted 20-fold in 200 ml of the same medium and grown to an optical density at
595 nm of 0.125. Bacterial cells were harvested by centrifugation and washed
three times in 10-ml volumes of ice-cold 0.5 M sucrose. After the final wash, the
pellet was resuspended in 1 ml of ice-cold 0.5 M sucrose, and 100-l aliquots of
the competent cells were used in transformation reactions. The transformation
reactions were performed with 1 to 5 g plasmid DNA using a Gene Pulser
electroporater (Bio-Rad, United Kingdom) with pulse settings of 2.5 kV cm1,
200, and 25 F, typically giving a pulse time of 4 to 6 ms. Ice-cold THB was
added to the transformed cells, which were then incubated at 37°C for 3 h to
allow cell recovery. Transformants were selected by plating serial dilutions of the
cells on THAE, followed by incubating them overnight at 28°C (the permissive
temperature) to allow plasmid replication.
To replace the wild-type lgt and prtM genes with their respective in-frame-
deleted alleles, transformants containing either pAH08 or pGprtM were sub-
jected to two rounds of homologous recombination as previously described by
Biswas et al. (5). The first recombination event, leading to the integration of
pAH08 or pGprtM into the strain 4047 chromosome, was achieved by growing
transformants at 28°C overnight and then increasing the temperature to 37°C for
3 h. Integrants were selected following growth on THAE overnight at 37°C. The
integrants were then inoculated into THBE and grown at 37°C overnight, fol-
lowed by dilution into THB and incubation at 28°C for a further 48 h. Incubation
at the permissive temperature allows plasmid replication and facilitates the
second recombination event. The bacteria were plated on THA and grown at
37°C to ensure excision of the free plasmid. Putative mutant colonies were
subcultured onto fresh THA and THAE plates to confirm their erythromycin
sensitivity. The presence of the mutant allele in the chromosome of putative
mutants was determined by PCR, using the primers SELGTAR 1U and SELGTAR
4L for the lgt mutants and the 5PRTM and 3PRTM primers for the prtM
mutants. PCR products, representing the deletion derivatives of each allele, were
generated using proofreading DNA polymerases, and the predicted deletions
were confirmed by DNA sequencing. DNA sequencing was performed by the
University of Newcastle Central Facility for Molecular Biology using an ABI
Prism 377 DNA sequencer or at the Animal Health Trust using an ABI3100
DNA sequencer with BigDye fluorescent terminators. A representative mutant
strain for each deleted allele was chosen for subsequent studies and designated
lgt190-685 or prtM138-213.
Analysis of the presence and localization of lipoproteins. Lack of Lgt activity
in the lgt190-685 mutant was confirmed by radiolabeling lipoproteins. Radiola-
beling of S. equi lipoproteins was performed as previously described by Sutcliffe
et al. (49).
In order to demonstrate the presence of surface-located lipoproteins in the S.
equi 4047 and S. equi lgt190-685 strains, transmission electron microscopy was
performed as described by Dixon et al. (14). Western blotting was used to
indicate the presence of lipoproteins in either cell extract or secreted protein
profiles. The preparation of bacterial cell extracts, sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE), and Western blotting were all
performed as previously described (21). SDS-solubilized cell extracts contained
a mixture of both soluble and membrane-associated proteins. The primary anti-
LppC antibody used in this study was kindly provided by Horst Malke and used
at the recommended dilution. Cell-associated and supernatant acid phosphatase
activities of the wild-type and mutant strains were determined spectrophoto-
metrically as previously described (21).
Investigation of the virulence of S. equi mutants in an in vitro colonization
model. Air interface respiratory organ cultures were constructed using equine
upper respiratory tract tissues (nasal turbinate, guttural pouch, and trachea) and
methods described for human (26) and canine (1) tissues with some modifica-
tions. Tissues were obtained from an abattoir and washed in Dulbecco’s modified
Eagle’s medium (DMEM) containing antibiotics (penicillin, 100 U ml1; strep-
tomycin, 50 g ml1; gentamicin, 100 g ml1; amphotericin, 2.5 g ml1) for
4 h to remove commensal flora. Following further washing in DMEM to remove
residual antibiotics and amphotericin, the tissues were dissected into pieces of
approximately 5 mm2 and mounted at an air interface on agarose platforms
surrounded by 2.5 ml DMEM in 6-well cell culture plates. Organ cultures were
maintained in a humidified 5% CO2 incubator. Viability of the air interface
organ cultures was assessed using polystyrene bead clearance (1). Contamination
was monitored by running a bacteriology loop around all four edges of the
culture pieces and streaking onto horse blood agar plates. Any tissue pieces in
which contamination was detected were discarded. Organ culture pieces were
infected with a 10-l suspension containing 1  105 CFU of wild-type S. equi
4047, lgt190-685, or prtM138-213 or were mock-infected with THB. Colonization
of organ culture pieces was assessed by measuring viable counts (six organ
culture pieces per time point) of adherent bacteria at 4 h and 24 h postinfection
(p.i.). Organ culture pieces were vortexed for 15 s in phosphate-buffered saline
to remove nonadherent bacteria and were then homogenized before being plated
for 10-fold serial dilutions onto THA for enumeration of the colonies. Changes
in the surface features of organ culture pieces (two per time point) in response
to infection with wild-type S. equi or the two mutants at 24 h p.i. were assessed
by morphometric analysis of scanning electron microscopy (SEM) images of the
epithelial surface. The tissues were processed and surface morphometry was
carried out using standard methods (26). The percentage of the epithelial surface
covered with mucus was recorded. The data represent the means and standard
deviations of the results of six independent experiments using tissues from
different horses. Differences in colonization and surface morphometry data were
tested for statistical significance using Mann-Whitney U tests and are reported at
the 5% level.
Investigation of the virulence of S. equimutants in a mouse model of strangles.
Mice were challenged intranasally as described by Chanter et al. (9). Briefly, 30
3- to 4-week-old female BALB/c mice were challenged with 4 106 CFU of fresh
cultures of wild-type 4047, prtM138-213, or lgt190-685 S. equi strains, and clinical
signs of disease, including weight loss and sneezing, were compared with those of
a group of 10 unchallenged controls over a period of 5 days. At the end of this
period, mice were euthanized and examined for signs of S. equi infection (mea-
sured as viable S. equi cell counts) and pathology by histological examination of
lymph nodes and tissues of the head and neck. The extent of pathology in each
mouse was then graded on the basis of pathological features most pertinent to S.
equi infection, using the following scoring system: lymphadenitis, 1; lymph node
abscess, 5; rhinitis, 1; marked rhinitis, 5; pharyngitis, 3; meningitis, 5; otitis media,
3; lung lesions, 5; and splenic lesions, 5.
Investigation of the virulence of S. equi mutants in a pony challenge study.
Groups of five naı¨ve, male yearling Welsh Mountain ponies were challenged with
either prtM138-213 or lgt190-685, and a similar control group of four male ponies
were challenged with S. equi 4047. Each group was housed separately throughout
the challenge period with strict infection control measures in place to ensure
there was no cross-contamination between the groups.
Fresh cultures of each strain were grown in THB supplemented with 10% fetal
calf serum (THB10) at 37°C with 5% CO2 to an optical density at 600 nm of 0.3.
Previous studies have shown that this density of bacteria corresponds to approx-
imately 2  108 CFU ml1 of S. equi 4047 (unpublished observations). At this
point, the cultures were diluted 1:8 in fresh prewarmed and pregassed THB10,
and 2 ml of challenge inoculum was administered via both nostrils, using a
flexible tube and spray nozzle, in order to administer approximately 1  108
CFU/pony. Clinical signs of disease, including fever, swelling of the lymph nodes,
and nasal discharge were monitored daily for up to 3 weeks. The ponies were
considered to be pyrexic when their temperatures exceeded 39.0°C. Clinical
scores were calculated according on the scoring system presented in Table 2.
Blood samples were collected to enable monitoring of the neutrophil levels
present in the challenged ponies. Normally, these range from 3 to 6.5 106 ml1
in healthy ponies but frequently exceed 1  107 ml1 during S. equi infection. At
the end of the study period, all of the ponies were euthanized and the extent of
their disease was quantified on postmortem examination, using the following
scoring system: abscess in a lymph node, 15; microabscess in a lymph node, 10;
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enlarged lymph node, 1; empyema of the guttural pouch, 5; follicular hyperplasia
of the guttural pouch, 1. Samples of lesions at postmortem were used to reisolate
the challenge organisms in order to confirm their identity by PCR of the lgt and
prtM genes.
Animal ethics. These studies were performed under a Home Office project
license after ethical review and following strict welfare guidelines.
RESULTS
Identification of the lgt gene and construction of an Lgt-
deficient allelic-replacement mutant. Our initial studies al-
lowed the amplification of a 261-bp internal fragment of the S.
equi 4047 lgt gene (GenBank accession number AJ403973),
using degenerate primers based upon conserved amino acid
sequences in the Lgt proteins of S. mutans, S. pneumoniae, and
S. pyogenes. The sequence was completed by subsequent PCR
experiments and verified by reference to an early release of the
S. equi 4047 genome project. Putative promoter and ribosome
binding site sequences were identified upstream of the lgt gene,
which is located downstream of the hprK gene as in several
other gram-positive bacteria (7, 24). The lgt gene of S. equi
4047 encodes a 259-amino-acid protein with a molecular mass
of approximately 29.8 kDa. The derived protein sequence con-
tains the Lgt Prosite motif G-R-X-[GA]-N-F-[LIVMF]-N-X-
E-X(2)-G (PS01311/PDOC01015) and matches the Pfam pro-
file (PF01790) for Lgt. An overlap-deletion PCR strategy was
used to create a mutant lgt allele with a 495-bp in-frame dele-
tion which removed this Prosite motif and was thus predicted
to produce a nonfunctional Lgt enzyme. Replacement of the
wild-type allele with the in-frame deletion derivative in S. equi
lgt190-685 was confirmed by PCR and sequencing.
Radiolabeling of lipoproteins in S. equi 4047 and S. equi
lgt190-685. To confirm the absence of Lgt activity in the allelic-
replacement mutant, S. equi 4047 and S. equi lgt190-685 were
grown in the presence of [14C]palmitate. Palmitate is incorpo-
rated into endogenous membrane lipids which are used as the
substrate for lipid modification of preprolipoproteins by Lgt,
thereby resulting in the radiolabeling of mature lipoproteins.
Electrophoresis of cell extract proteins of the parent strain
4047 revealed the presence of at least 10 distinct, radiolabeled
lipoproteins following autoradiography (Fig. 1, lane 1). In con-
trast, there was an absence of labeled protein bands in equiv-
alent cell extracts of the mutant strain (Fig. 1, lane 2). Intensive
labeling at the bottom of each lane indicated comparable in-
corporation of the labeled palmitate into bacterial lipids (Fig.
1). This result confirmed the absence of functional Lgt activity
in the mutant.
Investigation of the effect of the Lgt mutation on the pro-
cessing of a known S. equi lipoprotein. In order to determine
the effect of the Lgt mutation on the processing of an individ-
ual lipoprotein, the presence of the S. equi LppC acid phos-
phatase (21) was investigated in the wild-type and mutant
strains by Western blot analysis. As expected, a single cross-
reacting band representing the mature form of LppC was seen
in cell extracts of the parent 4047 strain probed with an anti-
body to the Streptococcus dysgalactiae subsp. equisimilis acid
phosphatase LppC (Fig. 2A, lane 2). When a cell extract of S.
equi 4047 which had been treated with globomycin was ana-
lyzed, a second cross-reacting band representing the proli-
poprotein-LppC (pro-LppC) form of the protein was seen (Fig.
2A, lane 1). The appearance of this additional, higher-molec-
ular-weight band is consistent with the inhibition of lipoprotein
signal peptidase II by globomycin (21). A cross-reacting dou-
blet was seen in cell extracts of S. equi lgt190-685 (Fig. 2A, lane
3), although the cross-reacting bands were considerably less
intense for this strain, despite a total protein load equivalent to
that of the wild type. Moreover, neither of the bands corre-
sponded in molecular weight with the pro-LppC form seen in
the globomycin-treated culture, suggesting that the preproli-
poprotein-LppC (prepro-LppC) form of the protein, which is
unlipidated but retains its signal peptide, migrates faster than
the pro-LppC form. The lower amount of cell-associated LppC
observed for S. equi lgt190-685 could be explained by a reduced
retention of prepro-LppC in the cell membrane as a conse-
quence of the inability of the mutant strain to modify this
protein with lipid. Consequently, we investigated the release of
FIG. 1. Labeling of lipoproteins from S. equi 4047 and the lgt190-685
mutant with [14C]palmitic acid. SDS extracts of cells grown in the
presence of radiolabeled [14C]palmitic acid were separated by SDS-
PAGE. The dried gel was exposed to X-ray film for 24 h before being
developed. Lane 1, S. equi 4047 extract; lane 2, S. equi lgt190-685
extract. The positions of molecular mass standards (in kDa) are shown
on the left.
TABLE 2. Scoring system used to quantify disease burden in ponies
Tissue type or symptom Grade Score
Nasala Normal 0
Serous 1
Mucopurulent 2
Submandibular lymph
node swellinga
Normal 0
Slight 1
Moderate 2
Severe 3
Cough Not present 0
Present 1
a Scores for the left and right sides were added.
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unlipidated LppC by performing Western blotting on concen-
trated culture supernatants obtained from the cultures from
which the cell extracts had been derived. There was a minor
but detectable cross-reacting protein in the supernatant of S.
equi 4047 but not in the supernatant of S. equi lgt190-685 (data
not shown). It was also noticeable that the band detected in the
supernatant of S. equi 4047 was smaller than the mature form
of the protein seen in cell extracts of the same strain, suggest-
ing that a proportion of the membrane-anchored LppC is re-
leased by proteolytic processing in the parent strain. Whole-
cell acid phosphatase assays were also performed for each
strain. As previously observed for S. equi strain 9682 (21), a
peak of acid phosphatase activity at a pH optimum of 5 was
readily detectable for S. equi 4047, but this activity was signif-
icantly reduced in the mutant strain S. equi lgt190-685 (Fig.
2B). However, acid phosphatase activity was undetectable in
the culture supernatants of both strains (data not shown),
suggesting that the protein detected in Western blots of S. equi
4047 culture supernatants is probably not active. Further con-
firmation of a reduced level of LppC in the cell envelope of the
mutant compared to that of the wild type came from LppC-
specific immunogold-labeling experiments. Single cocci of S.
equi 4047 and lgt190-685 (n  10 for each) were labeled with
234 	 20 and 54 	 20 gold particles, respectively. Cumula-
tively, these data suggested that there was a significant defect
in LppC localization within the cell envelope of S. equi
lgt190-685 compared to that of the parent strain.
Construction of a PrtM-deficient allelic-replacement mu-
tant. The S. equi lgt190-685 mutant had been shown to be
defective in the processing of lipoproteins generally (Fig. 1).
To gain further insight into the significance of specific lipopro-
teins in S. equi, we created a S. equi mutant strain defective in
the function of the putative maturase lipoprotein PrtM. The
PrtM sequence was identified from the S. equi genome project
and, in addition to its homology to pneumococcal PpmA (33),
it exhibits significant homologies to the maturase proteins of
other gram-positive bacteria (16, 19, 56, 57). This family of
sequences belongs to the parvulin family of PpiC-type peptidyl-
prolyl cis-trans isomerases (PPIase). A S. equi mutant
(prtM138-213) was constructed with an in-frame internal dele-
tion in the prtM coding sequence corresponding to the central
(parvulin-like) PPIase domain (57). This mutant is predicted to
synthesize a nonfunctional PrtM protein, although the absence
of an in vitro assay for PrtM function precludes experimental
confirmation of this. Growth of both the S. equi lgt190-685 and
the prtM138-213 mutants in nutrient-rich broth was compara-
ble to that of wild-type S. equi (data not shown).
Colonization of air interface organ cultures by S. equi
strains. Following inoculation of nasal turbinate, guttural
pouch, and tracheal organ culture pieces with 1  105 CFU
wild-type S. equi 4047 or the two mutants, all three strains were
recovered from all three tissues at 4 h p.i (Fig. 3A). At 24 h p.i.,
wild-type S. equi and lgt190-685 were again recovered, but
prtM138-213 was not detected. Wild-type bacteria were recov-
ered in statistically significantly higher numbers at both 4 h and
24 h p.i. from nasal turbinate (3.8 	 0.35; 3.4 	 0.55) and
guttural pouch (4.0 	 0.60; 4.2 	 0.70) cultures than from
tracheal cultures (2.8 	 0.25; 1.3 	 0.80). The numbers of
lgt190-685 cells recovered at 4 h and 24 h p.i. from turbinate
(3.9 	 0.50; 2.8 	 0.70), guttural pouch (3.2 	 0.45; 3.62 	
0.80), and tracheal (2.4 	 0.45; 1.1 	 0.60) cultures were not
significantly different from those of wild-type S. equi. However,
there were significantly fewer prtM138-213 cells than both wild-
type S. equi and lgt190-685 cells recovered at 4 h and 24 h p.i.
from nasal turbinate (1.8 	 0.30; 
0.7 	 0), guttural pouch
(1.4 	 0.45; 
0.7 	 0), and tracheal (0.7 	 0.50) cultures.
Changes in surface epithelial morphology of air interface
organ cultures exposed to S. equi strains. The surface mor-
phology of uninfected organ culture pieces from nasal turbi-
nate, guttural pouch, and trachea was predominantly ciliated
epithelium. The guttural pouch and tracheal cultures were
densely and uniformly ciliated, whereas nasal turbinate tissue
exhibited a mixture of ciliated and nonciliated epithelial cells.
For all three tissues after 24 h in culture, a small percentage of
the total epithelial surface area was covered with mucus (Fig.
3B) and the amount of surface coverage in the uninfected
control pieces was not significantly different from that at the
start of the experiment. Wild-type S. equi induced a marked
mucus response which resulted in a significantly greater pro-
portion of the epithelial surface being covered by mucus in all
three tissues (nasal turbinate, 86 	 18%; guttural pouch, 95 	
22%; trachea, 90 	 14%). The mucus formed a dense layer
that obscured the underlying ciliated epithelium (Fig. 4B).
Inoculation of lgt190-685 also induced a mucus response at 24 h
p.i. in all three tissues. The amount of mucus coverage of the
epithelial surface was significantly greater (nasal turbinate,
75	 12%; guttural pouch, 86	 16%; trachea, 82	 20%) than
FIG. 2. Changes in the nature (A) and the activity (B) of an acid
phosphatase (LppC) in the S. equi lgt190-685 mutant. (A) Proteins in
SDS extracts prepared from cells of the parent (4047) and mutant
strain (lgt190-685) were separated by SDS-PAGE and transferred to
nitrocellulose. Immunoblotting was carried out using a polyclonal an-
tibody raised to the LppC acid phosphatase of S. equisimilis. Lane 1,
globomycin-treated S. equi 4047; lane 2, S. equi 4047; lane 3, S. equi
lgt190-685. (B) Whole-cell acid phosphatase activity was determined
for strain 4047 (}) and the lgt190-685 mutant (■) across a range of pH
values by spectrophotometric changes associated with the release of
p-nitrophenol from the substrate p-nitrophenol phosphate. Results are
representative of three different experiments.
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FIG. 3. Colonization and morphometric analysis of air interface organ cultures infected with S. equi strains. (A) Recovery of viable bacteria 4 h and
24 h postinfection of nasal turbinate, guttural pouch, and tracheal air interface organ cultures with 1 x 105 CFU wild-type S. equi or the mutant lgt190-685
orprtM138-213. The data bars show the mean viable counts (	 the standard deviation [SD]) from six independent experiments. (B) Surface morphometric
analysis of nasal turbinate, guttural pouch, and tracheal air interface organ cultures 24 h after infection with 5 log10 CFU wild-type S. equi or the mutant
lgt190-685 or prtM138-213. The data bars show the mean percent surface coverage by mucus (	 SD) from six independent experiments.
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that for the uninfected control pieces but was not significantly
different from that of pieces infected with wild-type S. equi
(Fig. 3B). Qualitatively, the mucus layer produced appeared
less dense than that produced in response to wild-type S. equi
(Fig. 4C). In contrast to infection with both wild-type S. equi
and lgt190-685, inoculation with prtM138-213 did not result in a
significant increase in mucus production compared to that for
the uninfected control pieces (Fig. 3B), with the result that the
ciliated epithelial surface was not obscured by mucus (Fig. 4D).
Virulence of S. equi mutants in a mouse model of strangles.
The virulence of the mutants in a mouse intranasal infection
model of strangles was determined (9). As expected, approxi-
mately 60% of mice challenged with the parent 4047 strain lost
or failed to gain weight over the 5-day study period, indicative
of S. equi infection (Fig. 5A). S. equi 4047 also induced sneez-
ing from 3 days postchallenge (Fig. 5B) and induced significant
levels of disease in mice, as determined by postmortem exam-
ination 5 days postchallenge (Fig. 5C and D). Deletion of
either the lgt or prtM gene significantly attenuated S. equi on
intranasal challenge of mice as measured by weight gain,
sneezing rate, pathological score, and the overall incidence of
disease (Fig. 5A to D). Mice challenged with either lgt190-685
or prtM138-213 generally continued to gain weight in line with
the mock-challenged controls. However, 2 of 30 mice chal-
lenged with the lgt190-685 strain had reduced weight gain com-
pared with that of the unchallenged controls. Two mice chal-
lenged with lgt190-685, including one of the mice that had
failed to gain weight, also had histological disease on postmor-
tem examination (Fig. 5D).
Virulence of S. equi mutants in a pony challenge study. The
parent strain and both mutants were assayed for virulence in
Welsh Mountain ponies. The early clinical signs of strangles
disease such as pyrexia, nasal discharge, and swelling of the
submandibular lymph nodes were apparent from day 2 post-
challenge in 3 of 4 ponies challenged with the parental strain
4047 and from day 4 in 3 of 5 ponies challenged with the
lgt190-685 deletion mutant (Fig. 6A-C). In contrast, there
were no signs of disease observed in ponies challenged with
the prtM138-213 deletion strain throughout the 17-day study
period (Fig. 6A to C). There was a rise in mean rectal
temperature from day 4 postchallenge in the ponies chal-
lenged with wild-type 4047 compared to that for those chal-
lenged with either lgt190-685 or prtM138-213 (Fig. 6A).
Moreover, pyrexia (a temperature exceeding 39.0°C) was
evident in 3 of 4 of the 4047-challenged group compared
with 1 of 5 of the lgt190-685-challenged group and 0 of 5 of
the prtM138-213-challenged group (Fisher’s exact test, P 
0.048) (Fig. 6B). Other clinical signs were also significantly
reduced in prtM138-213-challenged ponies compared with
those in the wild type-challenged group (Kruskal-Wallis
test, P  0.0267) (Fig. 6C). There was no significant difference
in the mean clinical scores of the lgt190-685-challenged group
compared to those for the 4047-challenged ponies (Fig. 6C). Sim-
ilarly, whereas neutrophilia (6.5  106 ml1) was observed by
day 17 in both the wild type- and lgt190-685-challenged groups,
neutrophil levels in prtM138-213-challenged ponies remained sta-
ble (Fig. 6D).
On postmortem examination, lymph node abscesses were
apparent in all 4 ponies challenged with the parental 4047
strain, 3 of 5 ponies (P  0.44) challenged with the lgt190-685
strain, and 0 of 5 ponies (P  0.008) challenged with the
prtM138-213 strain (Fig. 7A). The mean pathological scores
FIG. 4. Morphology of air interface organ cultures exposed to S. equi strains. Representative SEM micrographs of uninfected nasal turbinate
organ culture pieces or pieces infected with 1  105 CFU wild-type S. equi or one of the two mutants after 24 h in culture. (A) Uninfected control;
(B) wild-type S. equi 4047; (C) lgt190-685; (D) prtM138-213. All images are shown at 2,000 magnification. Scale bars, 10 m.
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determined at postmortem were very similar for the 4047 and
lgt190-685 groups, whereas the low score obtained for the
prtM138-213 group reflected low-grade pathology not indica-
tive of strangles (Fig. 7B). S. equi was isolated from the ab-
scesses of ponies in the 4047 and lgt190-685 groups in high
yields (in excess of 109 CFU/ml of pus), and these isolates were
confirmed by PCR to have the full-length or truncated lgt gene,
respectively, thus confirming the source of infection and in vivo
stability of the lgt deletion. No S. equi was reisolated from any
of the prtM138-213-challenged ponies on postmortem exami-
nation, suggesting that this strain was not able to persist in vivo
for the 3-week duration of this study.
DISCUSSION
Comparatively little is known about the molecular basis of S.
equi virulence (22). Greater understanding should identify ra-
tional candidates for the development of an effective vaccine.
It is thought that prevention of strangles is likely to be the only
effective mechanism for combating the disease, as the lack of
vascularity associated with abscess formation prevents the de-
livery of effective doses of antibiotics and other drugs to the
sites of infection.
Bacterial lipoproteins are attractive as potential vaccine can-
didates, since they may be exposed on the bacterial surface and
FIG. 5. Challenge of mice with the lgt190-685 and prtM138-213 deletion strains. (A) The mean percent increase in weight per mouse was
calculated for each of the challenge groups. Mice succumbing to infection with wild-type S. equi (n  30) lost or failed to gain weight in
comparison to the uninfected controls (n  10). Groups of 30 mice challenged with the lgt190-685 (lgt) or prtM138-213 (prtM) mutant
continued to gain weight during the course of the study. Error bars indicate the standard error of the mean. * indicates a statistical
significance of P 
 0.05 compared with results for wild type-infected ponies. (B) The mean number of sneezes in 2 min for groups of five
cohoused mice was calculated for each of the challenge groups. Mice infected with the parental S. equi 4047 strain had a significantly elevated
sneezing rate compared with that of the uninfected and lgt190-685- and prtM138-213-challenged groups. Error bars indicate the standard error
of the mean. * indicates a statistical significance of P 
 0.05 compared with results for wild-type-infected ponies. (C) The extent of disease
on histological examination of mice was quantified according to the scoring system outlined in Materials and Methods. The mean total score
per mouse was calculated. Error bars indicate the standard error of the mean. * indicates a statistical significance of P 
 0.05 compared with
results for wild type-infected ponies. (D) The number of mice with histological signs of disease attributable to S. equi infection following
postmortem examination was compared to the number without histological signs of disease by Fisher’s exact test to determine if deletion
of the lgt or prtM genes significantly attenuated S. equi in the mouse infection model.
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thus may be potentially accessible to host immune molecules
(28, 51). Furthermore, a wide variety of functions has been
attributed to bacterial lipoproteins, at least some of which are
likely to be crucial to bacterial colonization and survival within
the host (46–48). Thus, immune responses directed at such
proteins may be highly opsonic and may also block the activity
of essential proteins. In the present study, we investigated the
contribution of lipoproteins to S. equi physiology and viru-
lence. To this end, we characterized the consequences of both
disrupting the lipoprotein biosynthetic pathway per se and
inactivating a specific lipoprotein, PrtM.
In order to construct a lipoprotein-deficient mutant of S.
equi 4047, the wild-type lgt gene was replaced by a mutant
allele that contained a 495-bp internal deletion that re-
moved the central portion of Lgt, including the highly con-
served sequence motif that defines the Lgt family of en-
zymes. An allelic-replacement strategy was chosen so as to
minimize the potential for polar effects due to the mutation.
The successful construction of an Lgt-deficient mutant (S.
equi lgt190-685) was confirmed by PCR and by palmitate
radiolabeling, which clearly showed that the mutant strain
lacked labeled lipoproteins (at least 10 of which could be
seen in the parent strain). That we could generate a viable,
Lgt-deficient mutant indicates that the absence of Lgt in S.
FIG. 6. Effect of intranasal challenge of ponies on rectal temperature, clinical scores, and neutrophil levels. (A) The rectal temperatures of the
ponies were taken daily from the day before challenge to day 17 postchallenge, and the mean temperature per pony for each challenge group is
shown. (B) The numbers of ponies in each group suffering from pyrexia were compared by Fisher’s exact test. Ponies were considered pyrexic when
their temperatures exceeded 39°C. Only ponies challenged with the prtM138-213 strain had a significantly reduced incidence of pyrexia (P 0.048).
(C) The mean clinical score for each challenge group was calculated according to the scoring system presented in Table 2. Comparison of the total
clinical score per pony over the study period using the Kruskal-Wallis test indicated that only the prtM138-213 deletion strain (prtM) was
significantly attenuated (P  0.0267). (D) The mean number of neutrophils per milliliter of blood was quantified for each pony. Ponies developed
signs of neutrophilia (neutrophil count of  6.5  106 ml1) 6 days postchallenge with the parental 4047 strain, whereas ponies challenged with
the lgt190-685 strain (lgt) developed neutrophilia 17 days postchallenge, and no signs of neutrophilia were observed in ponies challenged with the
prtM138-213 strain (prtM; P 
 0.05). Error bars indicate the standard error of the mean. * indicates a statistical significance of P 
 0.05 compared
with results for wild-type-infected ponies.
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equi is not lethal, a finding also observed for other gram-
positive organisms such as B. subtilis (12, 29, 39), S. pneu-
moniae (34), and S. aureus (45).
The failure to transfer a lipid moiety to preprolipoproteins
due to Lgt inactivation would likely result in either the accu-
mulation of signal peptide-anchored preprolipoproteins in the
cell membrane or the release of the lipoprotein derivatives into
the culture medium, due to either shedding or signal peptide
processing at “cryptic” signal peptidase I processing sites
(“shaving”). In order to determine which of these possibilities
did indeed occur for individual lipoproteins in the S. equi
lgt190-685 strain, the localization of a proven lipoprotein was
investigated by Western blot analysis. While it was clear that
there were reductions in the levels of LppC acid phosphatase
in cell extracts of the S. equi lgt190-685 mutant, there was no
corresponding increase in the amount of this protein in culture
supernatants. It appears, therefore, that the failure of this protein
to become lipid modified may result in its degradation, either
before or during secretion, although it remains possible that ex-
pression of this protein is altered in the S. equi lgt190-685 mutant.
Despite the demonstration, by palmitate labeling, that the S.
equi lgt190-685 mutant contained no detectable lipoproteins, a
protein cross-reacting with the anti-LppC antibody was present
in cell extracts of the S. equi lgt190-685 mutant, albeit at sig-
nificantly lower levels than in the parent strain. The cross-
reacting band also appeared to have a molecular weight very
similar to that of the wild-type (mature) lipoprotein. The most
likely explanation for this observation is that the LppC protein
seen in S. equi lgt190-685 is not lipidated but that the LppC
preprolipoprotein is proteolytically modified, yielding a prod-
uct similar in size to the mature acid phosphatase in the parent
strain. Comparable “mature-like lipoproteins” have been re-
ported previously for B. subtilis, L. monocytogenes, and S. suis
mutants lacking the Lsp signal peptidase II (13, 37, 53). Most
significantly, differential processing of lipoprotein precursors
has been observed in an lsp mutant strain of M. tuberculosis:
whereas the mutant accumulated both prolipoprotein and a
“mature-like” form of a 19-kDa lipoprotein, only the proli-
poprotein forms of a 27-kDa and the MPT83 lipoproteins
accumulated (40).
Although the phenotype of S. equi lgt190-685 did not corre-
spond with that originally predicted (i.e., preprolipoprotein
accumulation), convincing autoradiographic assays, Western
blotting analysis, acid phosphatase enzyme assays, and immu-
nolocalization data all confirmed a significant defect in li-
poprotein processing in this strain.
We intended to investigate the virulence of the S. equi
lgt190-685 mutant strain in a variety of in vitro and in vivo
models of colonization and disease and also decided to gener-
ate a mutant that was deficient in a single specific lipoprotein.
For the purpose of this study we chose the putative maturase
lipoprotein PrtM, one of four lipoproteins released in large
amounts by an Lgt mutant strain of S. aureus (45).
Air interface respiratory organ cultures of nasal turbinate,
guttural pouch, and tracheal tissues were used to compare the
abilities of wild-type S. equi, the lgt190-685 mutant strain, and
a PrtM-deficient mutant strain (prtM138-213) to colonize tis-
sues derived from a variety of anatomical sites within the
equine upper respiratory tract (URT) and to assess the re-
sponse of URT tissues to infection. Previous studies have
shown that culturing respiratory tract tissues at an air interface
provides a more physiological infection environment for bac-
terial pathogens than submerged culture systems (31, 59). Vi-
able and contamination-free tissues from all three regions were
successfully maintained for the duration of the experiment.
Colonization was assessed by measuring the numbers of bac-
teria adherent to tissues at 4 h and 24 h p.i. Wild-type S. equi
cells were present in higher numbers on nasal turbinate and
guttural pouch tissues than on tracheal tissues, suggesting less-
efficient colonization of the trachea. The numbers of cells of
the lgt190-685 mutant strain adherent to organ culture pieces
were not significantly different from those of wild-type S. equi,
suggesting that this mutant was capable of colonizing nasal
turbinate, guttural pouch, and tracheal tissues as efficiently as
wild-type bacteria. In contrast, however, cells of the prtM138-213
mutant were present in significantly reduced numbers com-
pared to those for wild-type S. equi in all three tissue sites at
both time points measured. These data suggest that the
prtM138-213 mutant strain has impaired ability to colonize the
equine URT.
The response of the equine URT to infection with wild-type
S. equi and the two mutants was assessed by SEM morphomet-
ric analysis of the epithelial surface. Uninfected cultures from
FIG. 7. Effect of intranasal challenge of ponies on the disease iden-
tified on postmortem examination. (A) The numbers of ponies in each
group with significant pathological signs of strangles attributable to
infection with S. equi on postmortem examination were compared
using Fisher’s exact test. Although 2 of 5 ponies challenged with the
lgt190-685 strain had no significant signs of disease, this was not statis-
tically significant (P  0.44). However, ponies challenged with the
prtM138-213 strain did have significantly reduced disease on postmor-
tem examination (P  0.008). (B) The mean pathology score per pony
was calculated for each of the challenge groups on postmortem exam-
ination using the scoring system outlined in Materials and Methods.
Error bars indicate the standard error of the mean. * indicates a
statistical significance of P 
 0.05 compared with results for wild-type-
infected ponies.
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all three anatomical regions had a small surface area covered
by mucus. Wild-type S. equi induced a marked mucus response
that obscured the epithelial surface. It was not possible to
assess the underlying epithelium by SEM analysis, although
light microscopy suggested that this was intact, and further-
more, organ culture pieces infected with the wild-type bacteria
continued to clear beads despite the production of mucus (data
not shown). This extensive mucus response has been noted for
other bacterial pathogens, using air interface organ cultures of
human (59) and canine (1) origin. The mutant lgt190-685 strain
also induced a marked mucus response that was not different
from that of wild-type S. equi. Although the amount of mucus
produced in these experiments was not quantifiable, the depth
of the mucus layer induced by lgt190-685 appeared thinner than
that produced by wild-type infection because the epithelial
surface could be discerned beneath. In contrast, prtM138-213
did not induce a mucus response, and organ culture pieces
infected with this mutant were indistinguishable from the un-
infected control pieces in this regard.
Taken together, the organ culture colonization and tissue
response data suggest that colonization of the URT (and/or
possibly production of soluble factors by the bacteria) is re-
quired to induce a mucus response. Wild-type S. equi and
lgt190-685 colonized the epithelium to a similar extent and
induced a similar mucus response, whereas prtM138-213 was
less able to colonize, was cleared from all tissue sites within
24 h p.i., and did not induce a mucus response. Since coloni-
zation is the first step in pathogenesis, these in vitro data
suggest that prtM138-213 is likely to have reduced virulence in
the natural host. However, note that persistence and abscess
formation in the horse would require evasion of the immune
response, which was not assessed in the air interface organ
culture models.
In the mouse S. equi model (9), challenge with the parental
S. equi 4047 strain induced disease in 57% (17 of 30) of mice
during the 5-day study period, as determined by changes in
weight gain, rate of sneezing, and histopathological analysis.
The deletion of the prtM gene significantly attenuated S. equi in
the mouse model of S. equi infection (P 
 0.001). None of the
mice challenged with prtM138-213 showed signs of disease (ei-
ther reduced weight gain or sneezing) throughout the study
period, and no disease was detected histologically. The lgt190-685
strain was also significantly attenuated in the mouse S. equi
infection model (P
 0.001). However, 3 of 30 mice challenged
with lgt190-685 had histological signs of disease and/or reduced
weight gain compared to that of the unchallenged controls,
indicating that this strain is not completely avirulent in mice.
Investigation of the in vivo virulence of the lgt190-685 and
prtM138-213 deletion strains was determined in the natural
host via intranasal challenge of Welsh Mountain ponies. Ponies
challenged with the parental S. equi 4047 strain developed
obvious signs of strangles during the 17-day study period, as
determined by pyrexia (3 of 4 ponies), clinical observations (4
of 4 ponies), and postmortem examination (4 of 4 ponies). The
prtM138-213 strain was significantly attenuated for each of
these parameters and did not induce signs of pyrexia (0 of 5
ponies; P  0.048), significant clinical signs of disease (0 of 5
ponies; P  0.027), or obvious signs of disease on postmortem
examination (0 of 5 ponies; P  0.008) during the same 17-day
study period. The presence of lymph node swelling in 1 of 5
ponies and follicular hyperplasia of the guttural pouch in all 5
ponies challenged with prtM138-213 may be indicative of an
immune response directed against this strain and suggests that,
although not detected at 17-days postchallenge, the prtM138-213
strain may persist for a short time in vivo. The lgt190-685 strain
generated early clinical signs of strangles in 3 of 5 ponies
challenged. S. equi isolates from the lesions in these ponies all
contained the deleted version of the lgt gene, indicating that
the strain had not reverted in vivo and thus that the presence
of functional Lgt is not an absolute requirement for virulence
in the natural host. However, there were no signs of strangles
in 2 of the 5 ponies challenged with lgt190-685, and there was
an overall reduction in the degree of pyrexia in this cohort.
This suggests that while this deletion mutant is not statistically
significantly attenuated in the pony, there was a trend toward
reduced incidence of disease compared with that for the pa-
rental 4047 strain, consistent with our findings for the other
models. The stronger attenuation of the lgt190-685 strain in the
mouse model compared with that in ponies may reflect differ-
ences in either the nature of bacterial-host interactions be-
tween the two species or differences in host responses to in-
fection. Note, for example, that the wild-type strain causes
disease in 100% of infected ponies but only 60% of infected
mice. Our data demonstrate that, ultimately, it is important to
evaluate virulence attenuation in the natural host.
The increased attenuation observed upon deletion of the
prtM gene compared with that upon deletion of the lgt gene
suggests that lack of lipidation of PrtM does not completely
eliminate its functional activity. In this context, it is important
to note that while deletion of lgt is not, in itself, lethal in B.
subtilis (12, 29, 39) the PrsA lipoprotein is essential: reduction
of the cellular levels of PrsA below a critical threshold of ca.
200 molecules per cell results in cellular lysis (56). Thus, it is
likely that some residual functional activity may be retained by
preprolipoproteins in Lgt mutants, perhaps during transient
membrane association prior to shedding, shaving, or proteo-
lytic degradation. Similar conclusions have previously been
drawn based on the absence of a significant growth defect in an
Lgt mutant of S. aureus (45) and an Lsp mutant of Lactococcus
lactis (55). In B. subtilis the in vivo function of PrsA apparently
derives from the interaction of the central parvulin-like do-
main with the flanking N- and C-terminal domains (57). How-
ever, a PrsA deletion mutant (PrsANC), which is comparable
to the prtM138-213 mutant described herein, was unable to
restore growth of PrsA-depleted cells, although it did exhibit
weak activity in an AmyQ secretion assay (57). Our studies
suggest that deletion of the central domain of S. equi PrtM is
sufficient to abrogate its function in vivo, thereby attenuating
this strain. Some maturases, such as the plasmid-encoded PrtM
of L. lactis, have clearly-defined substrates (19, 20), whereas
the role of the chromosomally encoded PpmA maturase has
not yet been defined (16). Similarly, PrsA of B. subtilis may
have a more pleiotropic role in protein secretion (57), and the
Bacillus anthracis genome encodes three functional PrsA ho-
mologues that may have distinct but overlapping substrate
specificities (58). Further analyses of the molecular conse-
quences of the deletion of prtM in S. equi are now required in
order to identify those virulence factors reliant on its activity
and which are essential to pathogenicity in the horse.
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